End-of-day quote
Shanghai S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
17.41
CNY
|
+2.29%
|
|
+1.34%
|
-16.54%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
8,694
|
9,387
|
7,834
|
-
|
Enterprise Value (EV)
1 |
8,694
|
9,387
|
7,834
|
7,834
|
P/E ratio
|
25.8
x
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
2.24
x
|
1.76
x
|
1.53
x
|
EV / Revenue
|
-
|
2.24
x
|
1.76
x
|
1.53
x
|
EV / EBITDA
|
-
|
23.3
x
|
14.2
x
|
10.8
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
2.62
x
|
2.01
x
|
1.87
x
|
Nbr of stocks (in thousands)
|
450,000
|
450,000
|
450,000
|
-
|
Reference price
2 |
19.32
|
20.86
|
17.41
|
17.41
|
Announcement Date
|
2/27/23
|
2/24/24
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
4,196
|
4,461
|
5,118
|
EBITDA
1 |
-
|
402.1
|
551
|
725
|
EBIT
1 |
-
|
231.8
|
383
|
537
|
Operating Margin
|
-
|
5.52%
|
8.59%
|
10.49%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
|
337.8
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
|
0.7500
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/23
|
2/24/24
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
4.85%
|
8.1%
|
10.6%
|
ROA (Net income/ Total Assets)
|
-
|
3.16%
|
5.2%
|
6.9%
|
Assets
|
-
|
-
|
-
|
-
|
Book Value Per Share
1 |
-
|
7.970
|
8.670
|
9.310
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
2 |
-
|
495
|
341
|
277
|
Capex / Sales
|
-
|
11.8%
|
7.64%
|
5.41%
|
Announcement Date
|
2/27/23
|
2/24/24
|
-
|
-
|
Last Close Price
17.41
CNY Average target price
28
CNY Spread / Average Target +60.83% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.54% | 1.08B | | +14.99% | 78.22B | | +8.38% | 8.84B | | -12.05% | 5.07B | | +53.66% | 4.82B | | +11.63% | 4.2B | | -23.67% | 2.28B | | +12.07% | 2.28B | | -32.35% | 2.12B | | +21.04% | 2.2B |
Specialty & Advanced Pharmaceuticals
|